223 related articles for article (PubMed ID: 3159188)
1. Membrane complement receptors specific for bound fragments of C3.
Ross GD; Medof ME
Adv Immunol; 1985; 37():217-67. PubMed ID: 3159188
[No Abstract] [Full Text] [Related]
2. Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b/C3b complement receptor (CR1).
Bohnsack JF; O'Shea JJ; Takahashi T; Brown EJ
J Immunol; 1985 Oct; 135(4):2680-6. PubMed ID: 3161946
[TBL] [Abstract][Full Text] [Related]
3. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
4. Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).
Wilson AB; Prichard-Thomas S; Lachmann PJ; Coombs RR
Immunology; 1980 Feb; 39(2):195-202. PubMed ID: 7380467
[TBL] [Abstract][Full Text] [Related]
5. Cell triggering by activated complement components.
Fishelson Z
Immunol Lett; 1985; 11(5-6):261-76. PubMed ID: 3912317
[No Abstract] [Full Text] [Related]
6. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
7. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3.
Myones BL; Dalzell JG; Hogg N; Ross GD
J Clin Invest; 1988 Aug; 82(2):640-51. PubMed ID: 2969921
[TBL] [Abstract][Full Text] [Related]
9. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
Ross GD; Lambris JD
J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
[TBL] [Abstract][Full Text] [Related]
10. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
Brown EJ; Joiner KA; Frank MM
J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
Medof ME; Kinoshita T; Nussenzweig V
J Exp Med; 1984 Nov; 160(5):1558-78. PubMed ID: 6238120
[TBL] [Abstract][Full Text] [Related]
12. Activation of the alternative pathway of complement by immune complexes and degradation of these complexes by macrophages.
Daha MR
Ann Immunol (Paris); 1982; 133C(2):245-52. PubMed ID: 7114798
[No Abstract] [Full Text] [Related]
13. Cell surface proteins reacting with activated complement components.
Becherer JD; Alsenz J; Servis C; Myones BL; Lambris JD
Complement Inflamm; 1989; 6(3):142-65. PubMed ID: 2526003
[TBL] [Abstract][Full Text] [Related]
14. Origin of the fourth component of complement related Chido and Rodgers blood group antigens.
Atkinson JP; Chan AC; Karp DR; Killion CC; Brown R; Spinella D; Shreffler DC; Levine RP
Complement; 1988; 5(2):65-76. PubMed ID: 2967744
[TBL] [Abstract][Full Text] [Related]
15. CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical review.
Wilson JG; Andriopoulos NA; Fearon DT
Immunol Res; 1987; 6(3):192-209. PubMed ID: 2960763
[No Abstract] [Full Text] [Related]
16. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum.
Schlesinger LS; Horwitz MA
J Clin Invest; 1990 Apr; 85(4):1304-14. PubMed ID: 2138634
[TBL] [Abstract][Full Text] [Related]
17. Mouse peritoneal macrophages cultured serum-free deposit complement on IgM-coated sheep erythrocytes in vitro.
Hetland G; Eskeland T
Acta Pathol Microbiol Immunol Scand C; 1987 Feb; 95(1):15-20. PubMed ID: 3554893
[TBL] [Abstract][Full Text] [Related]
18. Complement ligand-receptor interactions that mediate biological responses.
Fearon DT; Wong WW
Annu Rev Immunol; 1983; 1():243-71. PubMed ID: 6242465
[No Abstract] [Full Text] [Related]
19. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
20. The human C3b receptor.
Cook J; Kazatchkine M
Nouv Rev Fr Hematol (1978); 1983; 25(5):297-301. PubMed ID: 6228780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
